+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
New

Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 182 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5941555
Free Webex Call
10% Free customization
Description Jump to:

On-Body is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Wearable Injectors Market, valued at USD 8.62 Billion in 2024, is projected to experience a CAGR of 9.89% to reach USD 15.18 Billion by 2030. Wearable injectors are compact medical devices designed for controlled subcutaneous drug delivery, worn on the body to facilitate convenient and discreet medication administration. Growth in this market is primarily supported by the increasing global prevalence of chronic diseases requiring continuous self-treatment and the expanding demand for home-based healthcare solutions, which enhance patient autonomy.

Key Market Drivers

The increasing global prevalence of chronic diseases represents a primary driver for the wearable injectors market, necessitating continuous and often complex drug administration. Conditions like diabetes, cardiovascular disease, and autoimmune disorders demand regular, precise dosing over extended periods, making convenient delivery crucial. Wearable injectors offer an effective solution, enabling patients to manage therapies outside clinical settings, thereby supporting adherence and improving quality of life. Addressing this expanding patient population, according to Novo Nordisk, February 2025, Novo Nordisk Annual Report 2024, the company served over 45.2 million people living with serious chronic diseases in 2024, highlighting the critical demand for accessible drug delivery systems.

Key Market Challenges

The high initial cost associated with developing advanced wearable injectors presents a significant challenge to the Global Wearable Injectors Market. This substantial financial outlay directly hampers market expansion by elevating the final product price, which can limit widespread adoption. Such cost implications are particularly pronounced in regions with constrained healthcare budgets or limited reimbursement coverage, making these innovative devices less accessible to a broader patient population requiring continuous self-treatment.

Key Market Trends

Seamless digital integration and remote monitoring are transforming wearable injectors by embedding connectivity for real-time data exchange and patient oversight. This capability allows for continuous tracking of adherence, device performance, and patient physiological responses, leading to more informed treatment adjustments. According to France Biotech, in 2023, remote monitoring solutions demonstrated the highest growth in the digital health sector, increasing by four points compared to 2022 to represent 14% of digital health products. This integration supports decentralized care by extending clinical supervision into the home setting, improving patient safety and engagement.

Key Market Players Profiled:

  • Becton & Dickinson Co.
  • Johnson & Johnson Service Inc.
  • F. Hoffmann-La Roche Ltd.
  • Frederick Furness Publishing Ltd
  • Steady Med Therapeutics, Inc (United Therapeutics Corporation)
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • CeQur SA

Report Scope:

In this report, the Global Wearable Injectors Market has been segmented into the following categories:

By Type:

  • On-body
  • Off-body

By Technology:

  • Spring-based
  • Motor-driven
  • Rotary Pump
  • Expanding Battery
  • Other

By Application:

  • Oncology
  • Infectious Disease
  • Cardiovascular Disease
  • Autoimmune Disease
  • Immunodeficiency
  • others

By Region:

  • North America
  • South America
  • Aisa Pacific
  • Europe
  • MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wearable Injectors Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Wearable Injectors Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (On-body, Off-body)
5.2.2. By Technology (ring-based, Motor-driven, Rotary Pump, Expanding Battery, Other)
5.2.3. By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Immunodeficiency, others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Wearable Injectors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Wearable Injectors Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.2. Canada Wearable Injectors Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.3. Mexico Wearable Injectors Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
7. Europe Wearable Injectors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Wearable Injectors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.2. France Wearable Injectors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.3. United Kingdom Wearable Injectors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.4. Italy Wearable Injectors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.5. Spain Wearable Injectors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
8. Asia Pacific Wearable Injectors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Wearable Injectors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.2. India Wearable Injectors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.3. Japan Wearable Injectors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.4. South Korea Wearable Injectors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.5. Australia Wearable Injectors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
9. Middle East & Africa Wearable Injectors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Wearable Injectors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.2. UAE Wearable Injectors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.3. South Africa Wearable Injectors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
10. South America Wearable Injectors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Wearable Injectors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.2. Colombia Wearable Injectors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.3. Argentina Wearable Injectors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Wearable Injectors Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Becton & Dickinson Co.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Johnson & Johnson Service Inc.
15.3. F. Hoffmann-La Roche Ltd.
15.4. Frederick Furness Publishing Ltd
15.5. Steady Med Therapeutics, Inc (United Therapeutics Corporation)
15.6. Amgen Inc.
15.7. Insulet Corporation
15.8. Enable Injections
15.9. West Pharmaceutical Services, Inc.
15.10. CeQur SA
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Becton & Dickinson Co.
  • Johnson & Johnson Service Inc.
  • F. Hoffmann-La Roche Ltd.
  • Frederick Furness Publishing Ltd
  • Steady Med Therapeutics, Inc (United Therapeutics Corporation)
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • CeQur SA

Table Information

Report AttributeDetails
No. of Pages182
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.18 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Wearable Injectors Market Size, Share, Trends and Forecast by Type, Technology, Application, End Use, and Region, 2025-2033 - Product Image

Wearable Injectors Market Size, Share, Trends and Forecast by Type, Technology, Application, End Use, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Wearable Injectors - Global Strategic Business Report - Product Image

Wearable Injectors - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Wearable Injectors Market Report 2025 - Product Image

Wearable Injectors Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Medical Wearable Injector Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Medical Wearable Injector Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 170 Pages
  • Global
From
Patient Controlled Injectors Market Report 2025 - Product Image

Patient Controlled Injectors Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.